Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-21

Clinical Trial Update: 12-Week Study of Plecanatide for CIC (The CIC3 Study) [Phase 3]

View source ↗

Summary

Phase 3 trial update for plecanatide in chronic idiopathic constipation (CIC) completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plecanatide (plecanatide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-03-21